ArticleBiochemical genetics2026
Identification of the Dynamic Expression Patterns of Immune Genes in the Peripheral Blood of Acute Ischemic Stroke Patients.
Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Stroke is the second primary cause of death in the world and a main cause of disability, with ischemic stroke accounting for 80% of stroke cases. Under normal physiological conditions, there is a relative balance between the proinflammatory response and the anti-inflammatory response in brain tissue. Once ischemic stroke occurs, the balance is disrupted, and subsequent immune dysfunction occurs. However, the dynamic gene expression patterns underlying the immune-related mechanisms of acute ischemic stroke (AIS) are still not fully understood. In this study, through protein‒protein interaction network construction, random forest algorithm and immune cell subtype distribution evaluation, the 7 hub immune genes, namely, C5AR1, CD79B, TLR4, FLT3LG, IGF2R, NCR3 and PAK2, were identified. The peripheral blood of 60 AIS patients and 20 healthy controls was collected and grouped according to onset time and blood collection time. qRT‒PCR was used to measure the expression levels of hub immune genes in the peripheral blood mononuclear cells (PBMCs) of the AIS groups and control group. The results indicated that the hub immune genes were associated the onset and development of AIS. According to Pearson correlation analysis, the hub immune genes may be correlated with the dynamic immune response after AIS to some extent. In summary, our study identified 7 hub immune genes and verified the correlations between the 7 hub immune genes and the dynamic immune response after AIS. Furthermore, these genes may be novel candidate biomarkers or therapeutic targets in AIS.
Indexed as
Identifiers
41214317What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.